Advertising Confidentiality Document Public Use 
Patently-O
AUGUST 13, 2021
A new petition asks the court to examine the phrase again and help define when a document crosses the publication threshold. A new petition asks the court to examine the phrase again and help define when a document crosses the publication threshold. Centripetal Networks, Inc. Cisco Systems, Inc. , 869, 877 (Fed.
Fish & Richardson Trademark & Copyright Thoughts
FEBRUARY 4, 2021
As of March 23, 2020, Mylan’s NDA for Semglee™ was “deemed” to be a BLA, and Mylan has announced its submission of “all necessary documentation” to FDA for approval of Semglee™ as a biosimilar and interchangeable biosimilar product. Market uptake of biosimilars has generally trended upwards in 2020. FDA Addresses Biosimilar Competition.
Expert insights. Personalized for you.
91 
Let's personalize your content